Introduction
Antimicrobial resistance (AR) is a worldwide concern. It is expected that deaths linked to 45 antimicrobial resistance could rise from 700,000 to 10 million deaths per year by 2050 [1] . 46 On the other hand, 23 .000 (United States) to 25 .000 (Europe) deaths could be attributed to resistant pathogens in developed countries [2] .
48
In terms of economic loses, AR could cause a global loss of production as high as 100
49 trillion dollars which represents a huge impact on the economy of all countries, especially 70 generation cephalosporines, carbapenems and colistin, all of which are categorized as 71 highest priority [15] . Additionally, ESBL-and AmpC-producing E. coli, and carbapenem-72 resistant E. coli are listed as high priority organisms for which new antibiotics are urgently 73 needed [16] .
74
E. coli harboring resistance determinants originating in the poultry industry are therefore 75 of great epidemiological interest because they can serve as reservoirs of resistance 76 genes that can be transferred to human pathogens [17] . A relationship between resistant 77 strains of E. coli from poultry and those found in humans has been suggested in several 78 studies [18] [19] [20] . However, information about resistant E. coli in industrial poultry has been 79 poorly studied in Latin America. The objective of this study was to evaluate the 80 prevalence and AR patterns of and to characterize relevant resistance genes in ESBL 81
and AmpC E. coli from large poultry farms in Ecuador.
83
Material and methods 84 Study Design and Sampling 85 Pichincha, the province where Quito, the capital city of Ecuador is located, was selected 86 for the collection of samples since 36% of the total Ecuadorian broiler production is 87 located in this and surrounding provinces [21] . Eight large slaughterhouses are located 88 in Pichincha [21] and all were asked to participate in the study. Sampling [22] and for the AmpC phenotype using 111 boronic acid, ceftazidime and cefepime disks [23] .
112
Antimicrobial Resistance and PCR screening. 113 One isolate with the ESBL and AmpC phenotypes from each farm was selected for 114 analysis by the Kirby Bauer method. Antimicrobial resistance profiles were evaluated 115 using clinical breakpoint values from the Clinical and Laboratory Standards Institute [22] .
116
The following antibiotics were evaluated: trimethoprim-sulfamethoxazole, nalidixic acid, 117 ciprofloxacin, gentamicin, kanamycin, streptomycin, tetracycline, chloramphenicol, 118 fosfomycin, tetracycline, doxycycline, ceftazidime and ertapenem. E. coli ATCC 25922 119 was used as a quality control strain.
120
Selected isolates were studied by PCR to identify bla CTX-M , bla TEM , bla CMY , bla SHV and 121 bla KPC . PCR conditions and primers were those described by [24] for bla CTX-M , [25] for 122 bla TEM , [26] for bla CMY , [27] for bla SHV and [28] for bla KPC . Sub-families of bla CTX-M genes 123 were identified with PCR protocols described by [29] for bla CTX-M-1 , [30] for bla CTX-M-2 , [31] 124 for bla CTX-M-8 , [32] for bla CTX-M-9 and [33] for bla CTX-M-14-like . Isolates with phenotypic 125 resistance to colistin were tested for the presence of mcr-1 [ Genotypes III, VII, IX, XI and XIV were common to ESBL and AmpC isolates. In total, 237 genotypes VI and XI were the most common ones, with 14 and 11 isolates, respectively.
238
Isolates from each genotype originated from different farms.
240

Discussion
241
The aim of this research was to study antimicrobial resistance in E. coli from intensive 242 poultry farming. The lack of this kind of data from Latin America makes this study one of 243 the few available reports that demonstrate the extent of ESBL/AmpC E. coli in 244 commercial poultry in the region [38] [39] [40] . Nonetheless, developed countries have also 245 reported both a high prevalence of ESBL E. coli and the presence of multiresistant 246 isolates from broiler flocks [41, 42] . Similar to other studies, this research shows a higher prevalence of ESBL genes than 248 AmpC genes. However, a study carried out in Colombia by Castellanos et al. [39] 249 demonstrates a higher prevalence of AmpC genes in E. coli isolated from commercial 250 poultry. Differences in the epidemiologic patterns of enteric bacteria isolated from
251
Ecuadorian and Colombian poultry has been reported before and may be attributed to 252 the ecological characteristics of the boundary between these countries [13] .
253
High antimicrobial resistance rates and multi-resistance patterns could be related to the 254 intensive use of antimicrobials in poultry production, which in some cases are not only 255 used as therapeutics but also as prophylactics and growth promotors [11, 43] . On the 256 other hand, it has to be considered that the withdrawal of antibiotics from poultry 257 production systems may not result in the diminution of ESBL/AmpC E. coli since 258 ecological factors could be implicated in the dynamics of AR determinants [44, 45] .
259
Increasing antibiotic resistance and the lack of new antibacterial agents have revived 260 interest in old compounds such as nitrofurantoin in clinical [46, 47] . Despite the renewed 261 importance of nitrofurantoin and the known role of food animals in resistance 262 dissemination, only a few studies include this antibiotic in antimicrobial resistance 263 screenings [48, 49] .
264
Resistance rates to nitrofurantoin in this study are higher than the ones reported in 265 chicken meat samples (7,9%) in Colombia by Donado-Godoy et al. [49] . Higher
266
resistance to nitrofurantoin in extra-intestinal clinical isolates of E. coli from chickens has 267 been reported in China [48] . Due to the possibility that the resistance to nitrofurantoin 268 could increase over time, it is important to include it in antimicrobial resistance 269 surveillance plans in poultry production systems.
270
Carbapenems are not commonly used in the poultry industry, resulting in low selective 271 pressure by this antimicrobial in poultry production. This observation explains the low 272 prevalence of carbapenem-resistant E. coli reported in poultry [50] . Concordantly, we did 273 not identify any isolate resistant to ertapenem, although carbapenem resistance 274 mediated by bla KPC has been reported in clinical Enterobacteriaceae in Ecuador [51] .
275
The association of ESBL and AmpC phenotypes with increased prevalence of 276 aminoglycoside resistance has been reported [52] . In our study we identified a significant isolates were significantly more resistant to ceftazidime than ESBL isolates. This 283 difference is explained by the enhanced hydrolyzation of ceftazidime by the bla CMY gene 284 product [53, 54] .
285
Several studies throughout the world have reported plasmid-mediated colistin resistance 286 in Enterobacteriaceae pointing to its global emergence [55] . In our study 6 out of 176 287 isolates (3.4%) were PCR positive for mcr-1 and confirmed as phenotypically colistin 288 resistant. In contrast, a study in Argentina reported that 49% (n=304) of E. coli isolates 289 recovered from broilers were identified as colistin resistant by microdilution [56] . Another 290 study in Brazil reported that 19.5% of chicken meat samples (n=41) were positive for 291 mcr-1 [57] . Colistin resistant Enterobacteriaceae have been described in humans and 292 poultry in several Latin American countries [58, 59] . Considering these findings and 293 because colistin has been largely used as a growth promotor in Latin America, the poultry 294 industry could be considered an important hotspot for this kind of resistance. Additionally,
295
it has to be considered that although we did not find mcr-2 in our study, up to 8 genetic 296 determinants for colistin resistance have been described [60] [61] [62] . Therefore, a search for 297 more genetic determinants should be conducted to better understand the epidemiology 298 of colistin resistance in poultry from Ecuador.
299
Genes of the bla CTX-M family have been the most prevalent in several studies even when 300 there is no selective pressure due to antibiotic usage [44, 63] . In our study, the bla CTX-M 301 family was more prevalent than the AmpC genes. A study in Colombia showed that most 302 E. coli isolates from poultry had bla CMY genes [39] . This study showed that the most common variant of the AmpC gene was bla CMY-2 (58 isolates with bla CMY-2 and one bla CMY-304 46 isolate).
305
In our study, bla CTX-M-65 was the most prevalent allele of the bla CTX-M family ( [65] .
314
Likewise, bla CTX-M-3 and bla CTX-M- 55 have not been reported in Ecuadorian poultry isolates 315 but have been identified in human infections [34, 66] . These findings suggest the 316 presence of plasmids carrying these variants in our environment and the possibility of 317 transmission from poultry to human. Finally, 6 isolates did not present ESBL or AmpC 318 genes. In these cases, a broader panel of genes should be used to identify the genetic 319 determinants of resistance in these isolates.
320
The fact that different ESBL and AmpC genotypes originated from more than 1 farm,
321
suggests that cross contamination between farms is a plausible hypothesis. This idea is 322 supported by other studies that found that Salmonella and Campylobacter isolated from 323 different poultry farms are clonally related [67] . In Ecuador, climatic and social factors 324 lead to most poultry houses having an open configuration in which implementation of 325 rigorous biosecurity is difficult. Spread of bacterial genotypes among farms and 326 integrated companies can therefore be a common event [68, 69] . This highlights the 327 importance of implementing effective biosecurity systems aiming not only to avoid the 328 spread of antimicrobial resistance but also to improve poultry health.
329
In conclusion, poultry production systems represent a hotspot for antimicrobial 330 resistance in Ecuador, possibly mediated by the extensive use of antibiotics in this 331 industry. Monitoring this sector in national and regional plans of antimicrobial resistance 332 surveillance should therefore be considered.
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